Role of Histone Methyltransferase in Fibrosis and Traditional Chinese Medicine Treatment： A Review
10.13422/j.cnki.syfjx.20231118
- VernacularTitle:组蛋白甲基转移酶在纤维化疾病中的作用机制及其中药干预研究进展
- Author:
Jia WANG
1
;
Yuting HU
1
;
Yiyu LU
1
Author Information
1. Institute of Interdisciplinary Integrative Medicine Research， Shanghai University of Traditional Chinese Medicine， Shanghai 201203， China
- Publication Type:Journal Article
- Keywords:
histone methyltransferase;
fibrosis;
cellular and molecular mechanisms;
enhancer of zeste homolog 2 （EZH2）;
EZH2 inhibitor;
traditional Chinese medicines and their active ingredients
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2024;30(1):264-275
- CountryChina
- Language:Chinese
-
Abstract:
Fibrosis， a tumor-like lesion between benign tissue and malignant tumor， mostly occurs in the liver， kidney， heart， lung， bone marrow and other organs and tissues. It can affect almost every organ and eventually induce multiple organ failure and cancers， seriously endangering human life. It will be of great importance to prevent cancer if the disease can be opportunely blocked in the fibrotic stage. The pathogenesis of fibrosis is still not completely clear. It is of great clinical significance to study the occurrence， development， and mechanism of fibrosis as well as to screen new therapeutic targets. Enhancer of zeste homolog 2 （EZH2） is mainly located in the nucleus and involved in the formation of the polycomb repressive complex 2. EZH2 is a methyltransferase which makes the lysine on position 27 of histone H3 （H3K27me3） undergo trimethyl modification induces gene silencing through classical or nonclassical actions， so as to inhibit or activate transcription. EZH2 plays a critical role in cell growth， proliferation， differentiation， and apoptosis， which is regulated by different targets and signaling pathways. EZH2 regulates the transformation of myofibroblasts and participates in the fibrosis of multiple organs. Recent studies have shown that EZH2 plays a role in fibrosis-related pathophysiological processes such as epithelial-mesenchymal transition， oxidative stress， and inflammation. EZH2 as the target of fibrosis， EZH2 inhibitors， and EZH2-related traditional Chinese medicine （TCM） formula and active compounds have gradually become hot research directions. EZH2 may be a powerful target for organ fibrosis. Exploring the structure， function， and distribution of EZH2， the role of EZH2 in fibrosis， the EZH2 inhibitors， and TCM formulas and active components targeting EZH2 has great meanings. This paper reviews the research progress in EZH2 and fibrosis， providing new ideas for the diagnosis， treatment， and drug development of fibrosis.
